{
  "2023": [
    {
      "title": "CRISPR therapy wins global approval",
      "description": "2023 marked pivotal FDA and EMA approvals for CRISPR-based gene editing therapies, signaling the start of real-world gene editing in clinical practice.",
      "url": "https://www.nature.com/articles/d41586-023-03685-9",
      "morelink": "Nature"
    },
    {
      "title": "AI expands in biotech drug discovery",
      "description": "AI algorithms increasingly powered genomic analysis and compound screening, with platforms like DeepMindâ€™s AlphaFold accelerating molecular research.",
      "url": "https://www.deepmind.com/research/highlighted-research/alphafold",
      "morelink": "DeepMind"
    },
    {
      "title": "Synthetic biology drives lab-grown meat scale-up",
      "description": "Companies like Upside Foods and Eat Just advanced FDA clearance for cultivated meat, thanks to CRISPR and fermentation innovation.",
      "url": "https://www.foodnavigator-usa.com/Article/2023/06/05/Upside-Foods-and-Good-Meat-receive-final-FDA-clearance",
      "morelink": "Food Navigator"
    },
    {
      "title": "3D bioprinting matures",
      "description": "3D-printed tissue and vascular scaffolds gained regulatory attention, with research expanding toward skin grafts and functional organ prototypes.",
      "url": "https://www.labiotech.eu/medical/3d-bioprinting-organoids/",
      "morelink": "Labiotech"
    },
    {
      "title": "Agri-biotech enhances crop resilience",
      "description": "Gene-edited and drought-resistant crops were commercialized in 2023 to address food security and climate adaptation.",
      "url": "https://www.nature.com/articles/d41586-023-00945-1",
      "morelink": "Nature"
    }
  ]
}
